Induction_NN
of_IN
proto-oncogene_NN
and_CC
cytokine_NN
expression_NN
in_IN
human_JJ
peripheral_JJ
blood_NN
monocytes_NNS
and_CC
the_DT
monocytic_JJ
cell_NN
line_NN
THP-1_NN
after_IN
stimulation_NN
with_IN
mycoplasma-derived_JJ
material_NN
MDHM_NN
._.

Mycoplasma_NN
fermentans-derived_JJ
high-molecular-weight_JJ
material_NN
-LRB-_-LRB-
MDHM_NN
-RRB-_-RRB-
was_VBD
originally_RB
described_VBN
to_TO
induce_VB
differentiation_NN
of_IN
murine_JJ
thymocytes_NNS
to_TO
cytolytic_JJ
effector_NN
T-cells_NNS
by_IN
stimulating_VBG
IL-6_NN
release_NN
from_IN
adherent_JJ
cells_NNS
._.

This_DT
study_NN
shows_VBZ
that_IN
human_JJ
peripheral_JJ
blood_NN
monocytes_NNS
-LRB-_-LRB-
PBMo_NN
-RRB-_-RRB-
also_RB
respond_VBP
to_TO
MDHM_NN
with_IN
increases_NNS
in_IN
IL-1_NN
beta_NN
,_,
IL-6_NN
and_CC
TNF_NN
alpha_NN
expression_NN
,_,
both_CC
at_IN
the_DT
mRNA_NN
and_CC
protein_NN
level_NN
._.

The_DT
induced_JJ
expression_NN
of_IN
IL-1_NN
beta_NN
and_CC
TNF_NN
alpha_NN
mRNA_NN
in_IN
the_DT
monocytic_JJ
THP-1_NN
cell_NN
line_NN
increased_VBD
as_RB
quickly_RB
as_RB
in_IN
primary_JJ
cells_NNS
._.

In_IN
contrast_NN
to_TO
PBMo_NN
,_,
THP-1_NN
and_CC
14_CD
other_JJ
monocytic\/myeloid_JJ
leukemia-derived_JJ
cell_NN
lines_NNS
did_VBD
not_RB
secrete_VB
measurable_JJ
amounts_NNS
of_IN
the_DT
cytokines_NNS
upon_IN
treatment_NN
with_IN
MDHM_NN
._.

IL-1_NN
beta_NN
and_CC
IL-6_NN
genes_NNS
contain_VBP
AP-1_NN
binding_NN
sites_NNS
as_IN
regulatory_JJ
elements_NNS
,_,
the_DT
AP-1_NN
protein_NN
being_VBG
composed_VBN
of_IN
c-jun_NN
and_CC
c-fos_NN
gene_NN
products_NNS
._.

In_IN
THP-1_NN
cells_NNS
c-jun_NN
mRNA_NN
expression_NN
increased_VBD
after_IN
incubation_NN
with_IN
MDHM_NN
while_IN
positive_JJ
c-fos_NN
expression_NN
remained_VBD
unaffected_JJ
._.

Although_IN
these_DT
data_NNS
suggest_VBP
AP-1_NN
regulated_VBN
cytokine_NN
mRNA_NN
expression_NN
,_,
results_NNS
from_IN
PBMo_NN
are_VBP
not_RB
in_IN
accordance_NN
with_IN
this_DT
notion_NN
._.

In_IN
the_DT
primary_JJ
cells_NNS
MDHM-induced_JJ
elevation_NN
of_IN
cytokine_NN
mRNA_NN
levels_NNS
was_VBD
preceded_VBN
by_IN
a_DT
downregulation_NN
of_IN
c-fos_NN
expression_NN
while_IN
positive_JJ
c-jun_NN
expression_NN
was_VBD
not_RB
modulated_VBN
._.

c-myc_NN
mRNA_NN
expression_NN
,_,
constitutively_RB
high_JJ
in_IN
THP-1_NN
cells_NNS
,_,
was_VBD
induced_VBN
in_IN
MDHM-stimulated_JJ
PBMo_NN
._.

In_IN
conclusion_NN
,_,
MDHM-stimulated_JJ
induction_NN
of_IN
cytokine_NN
mRNA_NN
expression_NN
was_VBD
accompanied_VBN
by_IN
different_JJ
proto-oncogene_NN
responses_NNS
in_IN
PBMo_NN
and_CC
THP-1_NN
cells_NNS
._.

These_DT
differences_NNS
may_MD
represent_VB
different_JJ
regulatory_JJ
pathways_NNS
of_IN
the_DT
two_CD
cell_NN
systems_NNS
._.

Alternatively_RB
,_,
these_DT
data_NNS
support_VBP
the_DT
notion_NN
that_IN
neither_CC
AP-1_NN
nor_CC
the_DT
c-myc_NN
protein_NN
are_VBP
involved_VBN
in_IN
the_DT
MDHM-induced_JJ
increase_NN
in_IN
IL-1_NN
beta_NN
,_,
IL-6_NN
or_CC
TNF_NN
alpha_NN
mRNA_NN
levels_NNS
._.

Furthermore_RB
,_,
the_DT
present_JJ
results_NNS
demonstrate_VBP
clearly_RB
that_IN
mycoplasma_NN
products_NNS
can_MD
have_VB
a_DT
profound_JJ
impact_NN
on_IN
the_DT
activation_NN
status_NN
of_IN
eukaryotic_JJ
cells_NNS
._.

